Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30902412 | 0.83 | ALDH1A1 (0.55) | XDH | |
| SCHEMBL177342 | 0.81 | FDPS (0.54) | — | |
| SCHEMBL29445723 | 0.81 | XDH (0.54) | XDH | |
| SCHEMBL28714428 | 0.81 | XDH (0.54) | XDH | |
| SCHEMBL10088423 | 0.80 | XDH (0.51) | XDH | |
| SCHEMBL30262368 | 0.80 | FDPS (0.71) | — | |
| SCHEMBL7034558 | 0.80 | FDPS (0.71) | — | |
| SCHEMBL31573 | 0.80 | XDH (0.69) | XDHSLC22A12 | |
| SCHEMBL2344031 | 0.78 | XDH (0.53) | XDHSLC22A12 | |
| SCHEMBL25327365 | 0.78 | FDPS (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114105881-B | Platelet aggregation inhibitor, and preparation method and application thereof | 沈阳海诺威医药科技有限公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-3960734-B1 | PLATELET AGGREGATION INHIBITOR, PREPARATION AND USES THEREOF | SHENYANG HINEWY PHARMACEUTICAL TECH CO LTD (CN) | 2023-10-11 | — | — | EP | disclosed |
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | SHENYANG HINEWY PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2023-08-01 | — | — | US | disclosed |
| CN-114105881-A | Platelet aggregation inhibitor and preparation method and application thereof | 沈阳海诺威医药科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-102766099-B | There is compound and salt, preparation method and the purposes of xanthine oxidase inhibitory activity | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2015-09-23 | — | — | CN | disclosed |
| CN-102766099-A | Compound with xanthine oxidase inhibitory activity as well as salt, preparation methods and application thereof | UNIV SHENYANG PHARMACEUTICAL | 2012-11-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | TFPI, F12, TFPI2 | XDH 413/4885SLC22A12 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.